Karl-Anthony Towns saved the Knicks, even if they might not have asked him to become their savior. Just about every big play down the stretch Sunday was designed to free up Jalen Brunson, who ...

DENVER – George Karl hopped on his electric bicycle, put it in second gear and set off to ride away his blues. Last summer, the Hall of Fame basketball coach logged more than 1,300 miles on his ...

Knicks center Karl-Anthony Towns battled through a left hand injury in Saturday’s 115-93 loss to the Boston Celtics in Game 3 of the Eastern Conference Semifinals at Madison Square Garden.

DETROIT — With roughly 90 seconds remaining in one of those season-defining thrillers, Karl-Anthony Towns dribbled from the top of the key to the baseline. He was a good distance from the basket ...

According to Karl-Anthony Towns, it's not enough. "We've got to execute at a higher level in Game 2 if we expect to come out with a win," Towns bluntly declared in video from SNY. "We're just ...

Donald Trump lashed out at Howard Kurtz and Karl Rove, two Fox News personalities who have hardly been the president’s fiercest critics. In fact, Trump’s gripe about Kurtz was that his defense ...

Longtime Republican strategist Karl Rove criticized Beto O’Rourke as one of the Democratic Party’s “lesser lights” after O’Rourke said his fellow Democrats are lazy. Rove joined Fox News ...

Pundit Karl Rove warned President Trump is not in good standing with voters on economic issues as he closes in on the 100th day of his second term in the White House this week. “Well ...

Legendary GOP operative and Fox News contributor Karl Rove declared that President Donald Trump is in “very bad shape” during a scathing segment over the weekend. “Well, he’s [Trump] off ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

One company value investors might notice is Puma Biotechnology (PBYI). PBYI is currently holding a Zacks Rank of #2 (Buy) and a Value grade of A. PBYI is also sporting a PEG ratio of 1.38.